JP2022504650A5 - - Google Patents
Info
- Publication number
- JP2022504650A5 JP2022504650A5 JP2021519763A JP2021519763A JP2022504650A5 JP 2022504650 A5 JP2022504650 A5 JP 2022504650A5 JP 2021519763 A JP2021519763 A JP 2021519763A JP 2021519763 A JP2021519763 A JP 2021519763A JP 2022504650 A5 JP2022504650 A5 JP 2022504650A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- phenyl
- oxazole
- chlorobenzo
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862743920P | 2018-10-10 | 2018-10-10 | |
| US62/743,920 | 2018-10-10 | ||
| PCT/US2019/055493 WO2020077024A1 (en) | 2018-10-10 | 2019-10-10 | Benzoxazole and related compounds useful as chaperone-mediated autophagy modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504650A JP2022504650A (ja) | 2022-01-13 |
| JP2022504650A5 true JP2022504650A5 (https=) | 2022-10-03 |
| JP7503850B2 JP7503850B2 (ja) | 2024-06-21 |
Family
ID=70163886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519763A Active JP7503850B2 (ja) | 2018-10-10 | 2019-10-10 | シャペロン介在性オートファジー調節剤として有用なベンゾオキサゾールおよび関連化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12473266B2 (https=) |
| EP (1) | EP3863755A4 (https=) |
| JP (1) | JP7503850B2 (https=) |
| KR (1) | KR20210082466A (https=) |
| CN (1) | CN113195084B (https=) |
| AU (1) | AU2019358074A1 (https=) |
| BR (1) | BR112021006843A2 (https=) |
| CA (1) | CA3115297A1 (https=) |
| IL (1) | IL282069A (https=) |
| MX (1) | MX2021004134A (https=) |
| WO (1) | WO2020077024A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022015624A1 (en) * | 2020-07-16 | 2022-01-20 | Schrödinger, Inc. | Substituted dihydropyrazinediones as modulators of the nmda receptor |
| CN116438166A (zh) * | 2020-11-20 | 2023-07-14 | 豪夫迈·罗氏有限公司 | 用于治疗和预防乙型肝炎病毒感染的n-取代4-(1,3-芳基并噁唑-2-基)苯基化合物 |
| WO2022155333A1 (en) * | 2021-01-13 | 2022-07-21 | Albert Einstein College Of Medicine | Use of chaperone-mediated autophagy activators for treating or preventing blood cancers and myelodysplastic syndromes |
| KR102778740B1 (ko) | 2021-06-24 | 2025-03-07 | 주식회사 엘지화학 | 합성가스의 제조방법 |
| CN114404421B (zh) * | 2022-02-28 | 2023-04-28 | 同济大学 | 选择性自噬激活剂qx77在制备干预或治疗糖尿病视网膜病变的药物中的应用 |
| WO2024225738A1 (ko) * | 2023-04-25 | 2024-10-31 | 부산대학교 산학협력단 | 지방간질환 치료 또는 예방 목적의 fxr/ppar alpha 이중 작용 활성을 가지는 벤즈옥사졸 유도체 화합물 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH469802A (de) * | 1966-01-07 | 1969-03-15 | Ciba Geigy | Verwendung von Benzoxazol-Derivaten als Scintillator-Substanzen |
| US5428052A (en) * | 1984-09-19 | 1995-06-27 | Centre Internationale De Recherches Dermatologiques (C.I.R.D.) | Aromatic heterocyclic derivatives and their therapeutic and cosmetic use |
| JP3969741B2 (ja) * | 1995-11-17 | 2007-09-05 | マーク アンド カンパニー インコーポレイテッド | アセチルコリン受容体の修飾因子として役立つ新規置換アリール化合物 |
| WO2003048137A1 (en) | 2001-11-30 | 2003-06-12 | Merck & Co., Inc. | Metabotropic glutamate receptor-5 modulators |
| CN1636037A (zh) | 2002-02-21 | 2005-07-06 | 西巴特殊化学品控股有限公司 | 基于内酰胺的颜料及其在生产有色塑料或聚合有色颗粒中的应用 |
| PL1745041T3 (pl) | 2004-04-30 | 2012-11-30 | Genentech Inc | Inhibitory chinoksalinowe szlaku sygnałowego hedgehog |
| NZ552397A (en) * | 2004-07-15 | 2011-04-29 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| JP5301999B2 (ja) | 2005-10-31 | 2013-09-25 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｃｅｔｐ阻害薬 |
| RU2462458C2 (ru) * | 2006-02-10 | 2012-09-27 | Байомарин Ига Лимитед | Лечение миодистрофии дюшена |
| CA2641880C (en) * | 2006-02-10 | 2014-09-09 | Summit Corporation Plc | Treatment of duchenne muscular dystrophy |
| GB0602768D0 (en) * | 2006-02-10 | 2006-03-22 | Vastox Plc | Treatment of muscular dystrophy |
| AR066879A1 (es) | 2007-06-08 | 2009-09-16 | Novartis Ag | Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus |
| CA2685540C (en) | 2007-08-03 | 2018-10-16 | Graham Michael Wynne | Drug combinations for the treatment of duchenne muscular dystrophy |
| CA2737028C (en) | 2008-09-23 | 2017-06-27 | Wista Laboratories Ltd. | Ligands for aggregated tau molecules |
| JP2011168515A (ja) | 2010-02-17 | 2011-09-01 | Kowa Co | エリスロポエチン産生促進作用を有する２−アリールベンゾオキサゾール化合物 |
| US9512092B2 (en) * | 2013-12-12 | 2016-12-06 | Albert Einstein College Of Medicine, Inc. | Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof |
| EP3187495A1 (en) * | 2015-12-30 | 2017-07-05 | Johannes Gutenberg-Universität Mainz | 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| WO2017160116A2 (ko) * | 2016-03-17 | 2017-09-21 | 연세대학교 산학협력단 | 니코틴아미드 포스포리보실트랜스퍼라제 억제용 신규 화합물 및 이를 포함하는 조성물 |
| JP2018087173A (ja) | 2016-11-29 | 2018-06-07 | 国立大学法人北海道大学 | 悪性脳腫瘍治療薬 |
| JP7101678B2 (ja) | 2016-12-22 | 2022-07-15 | インサイト・コーポレイション | 免疫調節剤としての複素環式化合物 |
| US10676467B2 (en) | 2017-06-30 | 2020-06-09 | Washington University | Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof |
-
2019
- 2019-10-10 CN CN201980081709.XA patent/CN113195084B/zh active Active
- 2019-10-10 EP EP19871950.2A patent/EP3863755A4/en active Pending
- 2019-10-10 WO PCT/US2019/055493 patent/WO2020077024A1/en not_active Ceased
- 2019-10-10 KR KR1020217013722A patent/KR20210082466A/ko not_active Ceased
- 2019-10-10 US US17/283,613 patent/US12473266B2/en active Active
- 2019-10-10 CA CA3115297A patent/CA3115297A1/en active Pending
- 2019-10-10 BR BR112021006843-0A patent/BR112021006843A2/pt unknown
- 2019-10-10 AU AU2019358074A patent/AU2019358074A1/en not_active Abandoned
- 2019-10-10 JP JP2021519763A patent/JP7503850B2/ja active Active
- 2019-10-10 MX MX2021004134A patent/MX2021004134A/es unknown
-
2021
- 2021-04-05 IL IL282069A patent/IL282069A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022504650A5 (https=) | ||
| AU2016299485B2 (en) | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same | |
| US8436038B2 (en) | Indole and indazole compounds as an inhibitor of cellular necrosis | |
| AU2009330686B2 (en) | Compounds for the treatment of cancer | |
| RU2419624C2 (ru) | Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2 | |
| JP2010540462A5 (https=) | ||
| CN109803967A (zh) | 二氢嘧啶类化合物及其制备方法和用途 | |
| CA3105662C (en) | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same | |
| AR066424A1 (es) | Inhibidores de proteina activada de la 5- lipoxigenasa ( flap) | |
| JP2013510884A5 (https=) | ||
| JP2016509591A5 (https=) | ||
| HRP20140970T1 (hr) | Spoj azolkarboksamida ili njegova sol | |
| JP2015502335A5 (https=) | ||
| JP2009502948A5 (https=) | ||
| JP2014517808A5 (https=) | ||
| JP2010513319A5 (https=) | ||
| JP2013542267A5 (https=) | ||
| HRP20161116T1 (hr) | NOVI DERIVATI CIKLOHEKSILAMINA KOJI DJELUJU KAO AGONISTI β2 ADRENERGIČKOG RECEPTORA I ANTAGONISTI MUSKARINSKOG ACETILKOLINSKOG RECEPTORA M3 | |
| JP2015524483A5 (https=) | ||
| JP2022500472A5 (https=) | ||
| KR101511771B1 (ko) | 세포괴사 저해제로서의 인돌 및 인다졸 화합물 | |
| JP2007510629A5 (https=) | ||
| JP2013537913A5 (https=) | ||
| JP2021534254A5 (ja) | 心臓弁疾患を治療するための医薬組成物 | |
| JP2024542806A5 (https=) |